1. Home
  2. HRL vs NBIX Comparison

HRL vs NBIX Comparison

Compare HRL & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

HOLD

Current Price

$24.06

Market Cap

11.8B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$158.84

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRL
NBIX
Founded
1891
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
13.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
HRL
NBIX
Price
$24.06
$158.84
Analyst Decision
Buy
Strong Buy
Analyst Count
6
22
Target Price
$26.50
$180.91
AVG Volume (30 Days)
4.6M
984.1K
Earning Date
05-28-2026
05-05-2026
Dividend Yield
5.61%
N/A
EPS Growth
N/A
41.95
EPS
0.62
1.91
Revenue
$12,106,160,000.00
$161,626,000.00
Revenue This Year
$2.66
$24.73
Revenue Next Year
$1.62
$13.14
P/E Ratio
$39.02
$83.16
Revenue Growth
1.55
977.51
52 Week Low
$19.72
$122.14
52 Week High
$31.11
$169.57

Technical Indicators

Market Signals
Indicator
HRL
NBIX
Relative Strength Index (RSI) 64.50 51.40
Support Level $23.23 $153.30
Resistance Level $24.62 $160.08
Average True Range (ATR) 0.49 5.41
MACD 0.05 -1.42
Stochastic Oscillator 59.05 21.24

Price Performance

Historical Comparison
HRL
NBIX

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: